您的位置：
首页
>
农业专利
>
详情页
INHIBITION OF OXIDATIVE STRESS, GLYCATION, AND PROTEIN CROSSLINKING
专利权人:
THE REGENTS OF THE UNIVERSITY OF COLORADO; A BODY CORPORATE
发明人:
Ram Nagaraj,Mikhail Linetsky,Stefan Rakete,Rooban Nahomi
申请号：
US16637841
公开号：
US20200247846A1
申请日:
2018.08.13
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Compositions for the treatment and prevention of symptoms and disease conditions associated with oxidative and carbonyl stress, including advanced glycation end products (AGEs), and to methods using the compositions. In particular, the invention relates to compositions useful in the treatment of diabetic retinopathy and nephropathy, to compositions useful in the treatment of other retinal disorders including macular degeneration and cataracts.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
Phenyl or phenyl-goblin [3,2-b] pyridine compounds, thyroid hormone 500 inhibitors； pharmacological synthesis； used in the treatment of colon cancer, lung cancer, hematopoietic disease, liver cancer, breast cancer, diabetic retinopathy, degenerative diseases, glaucoma, abscess, diabetes, patients Neurological degeneration, etc.
Composition comprising the extracts and fractions of Gymnaster koraiensis for prevention or treatment of retinal diseases
method for preventing the onset of symptoms of a neurodegenerative disease in an individual predisposed to neurodegenerative disease, method of reducing oxidative stress in the brain of an individual afflicted with oxidative stress, method of treating an individual afflicted with mild cognitive degeneration and composition pharmaceutical
PEPTIDES FOR USE IN THE TOPICAL TREATMENT OF RETINAL NEURODEGENERATIVE DISESASES, IN PARTICULAR IN EARLY STAGES OF DIABETIC RETINOPATHY AND OTHER RETINAL DISEASES IN WHICH NEURODEGENERATION PLAYS AN ESSENTIAL ROLE
抗糖化剤
